HORIZON EUROPE
European
Scope:EU-funded early-stage Research on novel Medical Technologies and Devices is uncovering unique opportunities to benefits patients and support clinicians.
Medical Technology and Devices businesses are facing long and capital-intensive product development cycles, complex regulatory procedures, slow market uptake requiring the support of key opinion leaders and intensive follow-up with early adopters. In addition to a mature technology, a well thought-out and realistic exploitation path with emphasis on achieving market traction as proof of both clinical and market potential of the idea is needed.
Proposal submitted to this transition challenge call should aim to:
Perform the necessary R&D to advance from an existing proof-of-principle technology to a mature version to initiate clinical evaluation. Develop an exploitation strategy, qualitatively and quantitatively outlining the proposed path to patient and describing an investable proposition. Proposal submitted to this call can target any technology addressing important health needs in the direct clinical treatment and care of patients.
The EIC considers proposals...
see more
Scope:EU-funded early-stage Research on novel Medical Technologies and Devices is uncovering unique opportunities to benefits patients and support clinicians.
Medical Technology and Devices businesses are facing long and capital-intensive product development cycles, complex regulatory procedures, slow market uptake requiring the support of key opinion leaders and intensive follow-up with early adopters. In addition to a mature technology, a well thought-out and realistic exploitation path with emphasis on achieving market traction as proof of both clinical and market potential of the idea is needed.
Proposal submitted to this transition challenge call should aim to:
Perform the necessary R&D to advance from an existing proof-of-principle technology to a mature version to initiate clinical evaluation. Develop an exploitation strategy, qualitatively and quantitatively outlining the proposed path to patient and describing an investable proposition. Proposal submitted to this call can target any technology addressing important health needs in the direct clinical treatment and care of patients.
The EIC considers proposals with a requested EU contribution of up to a EUR 2.5 million and a duration of up to 3 years as appropriate.
For further information on your eligibility, please refer to the EIC Work Programme 2021 in section III.2.1.
see less
Consortium characteristics
:
The aid is European, you can apply to this line any company that is part of the European Community.
characteristics of the Proyecto
Expenses related to personnel working directly on the project are based on actual hours spent, based on company costs, and fixed ratios for certain employees, such as the company's owners.
Payments to external third parties to perform specific tasks that cannot be performed by the project beneficiaries.
They include the acquisition of equipment, amortization, material, licenses or other goods and services necessary for the execution of the project
Miscellaneous expenses such as financial costs, audit certificates or participation in events not covered by other categories
Overhead costs not directly assignable to the project (such as electricity, rent, or office space), calculated as a fixed 25% of eligible direct costs (excluding subcontracting).
Characteristics of financing
Additional information about the call
other advantages
similar aids
| Próximamente
| Próximamente
| Próximamente